Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The promoter regions of the three mammalian transforming growth factor-beta genes (TGF-beta s 1, 2, and 3) have been recently cloned and characterized. The sequences show little similarity, suggesting different mechanisms of transcriptional control of these genes. To study differences in transcriptional regulation of mammalian and avian TGF-beta, we have cloned and sequenced the 5'-flanking region of chicken
TGF-beta 3
. Characterization of this region showed a TATA box and cAMP-responsive element (CRE) and AP-2 binding site consensus sequences starting at 12 and 28 base pairs, respectively, upstream from the TATA box. Moreover, four additional AP-2-like sites, 10 binding sites for the transcription factor Sp1, as well as two AP-1-like sites were also identified. Except for 32 base pairs of identity centered around the TATA box and CRE site and four other relatively small regions of identity, the chicken
TGF-beta 3
promoter was found to be structurally very different from the human
TGF-beta 3
promoter. Promoter fragments were cloned into a
chloramphenicol acetyltransferase
reporter plasmid to study functional activity. Basal transcriptional activity of the promoter was regulated in quail fibrosarcoma QM7 cells and in human adenocarcinoma A375 cells by multiple upstream elements including the TATA, CRE, and AP-2 sites. As in the human
TGF-beta 3
promoter, the CRE site showed activation by forskolin, an effect which could be shown by expression of
TGF-beta 3
mRNA in cultured chicken and quail cells as well. Our results indicate a complex pattern of transcriptional regulation of the chicken
TGF-beta 3
gene and suggest that differences in the regulation of expression of the genes for mammalian and avian
TGF-beta 3
may result in part from the unique structure of their 5'-flanking regions.
...
PMID:Identification and characterization of the chicken transforming growth factor-beta 3 promoter. 140 6
We have cloned and sequenced the 5' untranslated region of the transforming growth factor-beta 3 (
TGF-beta 3
) mRNA as well as the adjacent genomic sequence. S1 nuclease analysis identified a single transcription start site. We have thus determined that the 5' untranslated region is about 1.1 kb long and contains 11 open reading frames. In vitro translation of the
TGF-beta 3
precursor coding sequence was markedly inhibited by the presence of the 5' untranslated region. Similarly, when the 5' untranslated region of
TGF-beta 3
was introduced upstream of the coding sequence of
chloramphenicol acetyltransferase
, in vitro translation was inhibited. Furthermore, upon transfection into 293 cells,
chloramphenicol acetyltransferase
expression was inhibited by the 5' untranslated region of
TGF-beta 3
. The degree of translational inhibition was inversely proportional to the amount of transfected DNA. Mutation analysis implicated multiple segments of the 5' untranslated region as contributing to the inhibitory effect. Deletion of much of the 5'-most 640 nucleotides, including 8 of the 11 upstream ATGs, relieved much but not all of the inhibitory influence of the 5' untranslated region of
TGF-beta 3
mRNA. The two upstream open reading frames closest to the initiator codon for the
TGF-beta 3
coding sequence also decreased translational efficiency, since mutation of either ATG resulted in increased translation. Transfection results with T47-D cells, a cell line which expresses
TGF-beta 3
mRNA, were similar to those obtained with the 293 cell line. Thus,
TGF-beta 3
mRNA is a recent example of an expanding group of growth-related mRNAs in which the 5' untranslated region contains upstream open reading frames and other sequences which inhibit translation.
...
PMID:Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5' untranslated region. 187 22
Transforming growth factor beta 3 (
TGF-beta 3
) has been cloned from humans, chickens, pigs, and mice. Although the specific in vivo roles of this form of TGF-beta are unknown, the pattern of embryonic and tissue-specific expression of
TGF-beta 3
suggests that it is involved in embryogenesis and cell differentiation. We have cloned and sequenced the
TGF-beta 3
5'-flanking region to study the transcriptional regulation of this gene. Characterization of the 5'-flanking region showed a 1104-base pair 5'-untranslated region, a TATA box 21 bp upstream from the transcription start site, and cAMP-responsive element (CRE) and AP-2 binding site consensus sequences starting at 12 and 24 bp, respectively, upstream from the TATA box. Promoter fragments were cloned into a
chloramphenicol acetyltransferase
reporter plasmid to study functional activity. Basal transcriptional activity of the promoter was regulated by multiple upstream elements including the CRE and the AP-2 site. The CRE was important for both basal and forskolin induction of promoter activity. The
TGF-beta 3
promoter was found to be strikingly dissimilar to the TGF-beta 1 promoter. Since the TGF-beta s have activity in promoting or inhibiting proliferation and differentiation of multiple cell types, it seems likely that the differential and tissue-specific transcriptional regulation of these genes is of fundamental importance in the induction and maintenance of differentiated cell types in various tissues.
...
PMID:Structural and functional characterization of the transforming growth factor beta 3 promoter. A cAMP-responsive element regulates basal and induced transcription. 214 70
The mRNA for transforming growth factor beta 3 (
TGF-beta 3
) includes a long (1.1-kb) 5' noncoding region which exerts a potent inhibitory effect on translational efficiency. We now report that many human breast cancer cell lines (T47-D, SK-BR-3, ZR-75-1, and BT-474) express two mRNA species for
TGF-beta 3
: the 3.5-kb transcript previously described as the only
TGF-beta 3
mRNA species in cells and a novel 2.6-kb transcript which lacks approximately 870 nucleotides from the 5' noncoding region. The 5' end of the shorter transcript was sequenced, establishing it to be a 5' truncation of the full-length
TGF-beta 3
transcript. Estradiol decreased mRNA levels of both
TGF-beta 3
mRNA transcripts to an equivalent degree in estrogen receptor-positive cells. In contrast, the synthetic progestin gestodene altered the relative abundance of the two transcripts, preferentially diminishing the expression of the 2.6-kb transcript. The potential for enhanced mRNA translation attributable to the shorter 5' noncoding region was evaluated by transfection of cells with chimeric plasmid constructs in which the transcription unit consisted of coding sequence for
chloramphenicol acetyltransferase
downstream of the 5' noncoding sequence from
TGF-beta 3
. The translational efficiency of
chloramphenicol acetyltransferase
-encoding mRNA containing the shorter 5' noncoding region of the 2.6-kb
TGF-beta 3
transcript was approximately seven times greater than with the full-length 5' noncoding region of
TGF-beta 3
. Polysome analysis of
TGF-beta 3
mRNA in SK-BR-3 cells supported the hypothesis that the 2.6-kb transcript was more actively engaged in translation.
...
PMID:Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells. 826 30
Chimeric plasmids containing selected reporter coding domains and portions of the transforming growth factor beta 1 (TGF-beta 1) 3' untranslated region (UTR) were prepared and used to identify potential mechanisms involved in regulating the biosynthesis of TGF-beta 1. Transient transfections with core and chimeric constructs containing the
chloramphenicol acetyltransferase
(
CAT
) reporter showed that steady-state
CAT
mRNA levels were decreased two- to threefold in response to the TGF-beta 1 3' UTR. Interestingly,
CAT
activity was somewhat increased in the same transfectants. Thus, production of
CAT
protein per unit of mRNA was stimulated by the TGF-beta 1 3' UTR (approximately fourfold in three cell lines of distinct lineage). The translation-stimulatory effect of the TGF-beta 1 3' UTR suggested by these studies in vivo was confirmed in vitro by cell-free translation of core and chimeric transcripts containing the growth hormone coding domain. These studies showed that production of growth hormone was stimulated threefold by the TGF-beta 1 3' UTR. A deletion analysis in vivo indicated that the GC-rich domain in the TGF-beta 1 3' UTR was responsible for both the decrease in mRNA levels and stimulation of
CAT
activity-mRNA. We conclude that this GC-rich domain can have a bifunctional effect on overall protein expression. Moreover, the notable absence of this GC-rich domain in TGF-beta 2,
TGF-beta 3
, TGF-beta 4, and TGF-beta 5 indicates that expression of distinct TGF-beta family members can be differentially controlled in cells.
...
PMID:A GC-rich domain with bifunctional effects on mRNA and protein levels: implications for control of transforming growth factor beta 1 expression. 849 72